Jark Pharma Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 09-07-2024
- Paid Up Capital ₹ 0.21 M
as on 09-07-2024
- Company Age 23 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 91.45%
(FY 2022)
- Profit 37.10%
(FY 2022)
- Ebitda 46.44%
(FY 2022)
- Net Worth -16.41%
(FY 2022)
- Total Assets 9.59%
(FY 2022)
About Jark Pharma
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.21 M, as per Ministry of Corporate Affairs (MCA) records.
Rajesh Movaliya, Satish Movaliya, Maganbhai Movaliya, and Four other members serve as directors at the Company.
- CIN/LLPIN
U24231GJ2001PTC039355
- Company No.
039355
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
28 Mar 2001
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Rajkot, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Jark Pharma Private Limited offer?
Jark Pharma Private Limited offers a wide range of products and services, including Pharma & Bioanalytical Services, Pharmaceutical Services, Health Conditions, Respiratory Care, Skin Care, Sanitizers & Handwash, Popular Category, Stomach Care, Hair Care, Hair Oils.
Who are the key members and board of directors at Jark Pharma?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajesh Movaliya  | Managing Director | 01-Jun-2016 | Current |
Board Members(6)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Kailesh Movaliya | Director | 01-Jun-2016 | Current |
| Satish Movaliya | Director | 01-Jun-2016 | Current |
| Maganbhai Movaliya | Director | 01-Jun-2016 | Current |
| Nayanbhai Movalia | Director | 01-Jun-2016 | Current |
| Gandubhai Movaliya | Director | 01-Jun-2016 | Current |
| Shaileshbhai Movaliya | Director | 01-Jun-2016 | Current |
Financial Performance and Corporate Structure Insights of Jark Pharma.
Jark Pharma Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 91.45% increase. The company also saw a substantial improvement in profitability, with a 37.1% increase in profit. The company's net worth observed a substantial decline by a decrease of 16.41%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Jark Pharma?
In 2019, Jark Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Elevator & Escalator Component Manufacturers' Association Of IndiaActive 4 years 3 monthsNayanbhai Movalia is a mutual person
Captain Tractors Private LimitedActive 30 years 6 monthsRajesh Movaliya, Satish Movaliya and 5 more are mutual person
Captain Agri Machinery Exim LlpActive 9 years 10 monthsRajesh Movaliya, Satish Movaliya and 3 more are mutual person
- Ralos Energy Exim LlpActive 1 year 2 months
Rajesh Movaliya, Satish Movaliya and 1 more are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Jark Pharma?
Jark Pharma has a workforce of 11 employees as of Apr 10, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Jark Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Jark Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
